GUIDE FOR THE NEW ELECTRONIC PAYMENT SYSTEM. Version 1.0 Spanish Agency of Medicines and Medical Devices
|
|
- Rodney Hill
- 6 years ago
- Views:
Transcription
1 GUIDE FOR THE NEW ELECTRONIC PAYMENT SYSTEM Version 1.0 Spanish Agency of Medicines and Medical Devices
2 NEW ELECTRONIC PAYMENT SYSTEM INTRODUCTION AND ENTRY TO THE SYSTEM DEPARTMENT OF MEDICINES FOR HUMAN USE DEPARTMENT OF INSPECTION AND CONTROL DEPARTMENT OF VETERINARY MEDICINES DEPARTMENT OF COSMETICS AND MEDICAL DEVICES NOTIFIED BODY FEES AND SUMMARY WAYS OF PAYMENT
3 INTRODUCTION This change in the fee payment system arises from the need to facilitate the payment of fees to all pharmaceutical laboratories, companies and citizens. The philosophy of this new system is based on the adaptation of the Law 1/2015 in the article 123 and following, with regard to the fees of the different services provided by the Agency to the citizens. So that now, the user will choose the department of the AEMPS to which he wants to pay a fee, and then will choose one of the services and subservice that entails the payment of fees. The choice of services and subservices will result in the payment of a fee and obtaining document The system interface has been changed. The. system has only one entry and it has different exits, it means, it has different ways of payment.
4 ENTRY TO THE SYSTEM The entry to the system has not changed. The access is through the Electronic Headquarters. Click here, and you will acess the new application The Fee Payment button will redirect you to fees form. The Fee Consultation button will redirect you to payment consultation. This service is only available in the case of credit card payment and Open Line La Caixa for Caixa customers.
5 ENTRY TO THE SYSTEM When you press the button Payment of fees it appears a screen with different tabs at the top The first screen refers to the Identifying data of the taxable person and the Payer. In each of these Screens you can advance and go back to the previous screen at any time
6 NEW ELECTRONIC PAYMENT SYSTEM DEPARTMENT OF MEDICINES FOR HUMAN USE
7 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE On the Service tab you will choose: The Scope, which will match with each of the Departments of the AEMPS that provide services with payment of fees. The Type of Service The type of Subservice where appropriate Type of medicines in your case
8 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE For the Department of Medicines for Human Use, services that are subject to the payment of fees have been defined. The services that can be paid through the electronic payment system for the aforementioned department are: New register Booking vacancy Modification of authorization Renewal of authorization Ownership transfer National Annual Fee Parallel import Clinical trial Batch Release Certification Scientific Advice Others
9 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE Booking Vacancy.It is only paid in case of decentralized procedures where Spain acts as an EMR. In this screen you will choose the type of medicines for which you want to make the booking vacancy. The fee paid for this service is the "1.20 Fee for booking a vacancy to act as a Member State of Reference in a Decentralized or Mutual Recognition procedure." New register. We have thus defined the requests for authorization of new medicines, in the case of Human Use; Full application, Generics, Gases, Homeopathic with IT without IT, Plants MPT and Use well established and Allergens The fees paid for this services are : 1.1 Fee for the evaluation, authorization and registration of a new medicinal product for human use (authorization file submitted under Article 17, except for that referred to in 17.3) 1.2 Fee for the evaluation, authorization and registration of a new generic medicinal product for human use (authorization file submitted under Article Fee for the evaluation, authorization and registration of a new medicinal gas 2.1 Fee for the national procedure for the evaluation, authorization and registration of a new allergen medicinal product for human use for diagnostic use.
10 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE 3.1 Evaluation, authorization and registration of a new traditional herbal medicinal product (MTP) 3.3 Evaluation, authorization and registration in the register of a new herbal medicinal product for well-established use 4.1 Assessment, authorization and registration of a new homeopathic medicinal product without approved therapeutic indication Fee for a national simplified procedure. A single strain 4.2 Assessment, authorization and registration of a new homeopathic medicinal product without approved therapeutic indication Fee for a national simplified procedure. BETWEEN TWO AND FIVE BAYS 4.3 Assessment, authorization and registration of a new homeopathic medicinal product without approved therapeutic indication Fee for a national simplified procedure. MORE THAN SIX BODIES 4.5 Evaluation, authorization and registration of a new Homeopathic Medication with approved therapeutic indication
11 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE Modification of Authorization. We have defined this service for payments of variations, groupings, work-sharing, super groups and parallel presentations. When we choose this service, we will pay the following fee headings with their exceptions, and specific considerations included in the law VARIACION MEDICAMENTO HUMAN AND VETERINARY USE. 1.5 Fee by the procedure of modification of the authorization of a medicine of human use, classified as of "major importance" Type II 1.6 Fee for the procedure to modify the authorization of a medicinal product for human use, classified as Type IB 1.7Fee for the procedure for modifying the authorization of a medicinal product for human use, classified as type IA (including immediate notification types IA) 2.3 Fee for the procedure of modification of the authorization of an allergen medicine for diagnostic use, classified as "major importance" Type II. 2.4 Fee by the procedure of modification of the authorization of an allergen medicine for diagnostic use, defined as Type IB. 2.5 Fee by the procedure of modification of the authorization an allergen medicine for diagnostic use, qualified type IA (including types IA of immediate notification). 3.2 Modification of authorization of a traditional herbal medicinal product (MTP) 3.5 Modification of the authorization of a herbal medicinal product for human use classified as "of major importance Type II. 3.6 Modification of the authorization of a herbal medicinal product for human use classified as Type IB 3.7 Modification of the authorization of a herbal medicinal product for human use classified as Type IA (including immediate notification type IA) 4.4 Fee by the procedure of modification of the authorization of a Homeopathic Medicine without approved therapeutic indication 4.7Fee for the procedure of modification of the authorization of a Homeopathic Medicine with approved therapeutic indication, classified as of "major importance" Type II 4.8 Fee for the procedure of modification of the authorization of a Homeopathic Medication with approved therapeutic indication, classified as Type IB 4.9 Fee for the procedure of modification of authorization of a Homeopathic Drug with approved therapeutic indication, classified as Type IA
12 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE
13 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE Certification. This service has been defined for the payment of export certificates fee of Medicines for Human Use and all certifications that are paid with 7.1 Fee for issuing a certificate.
14 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE Scientific Advice. Services regarding scientific advice provided by the AEMPS to the laboratories have been defined. These services are in line with the fee headings 7.2,7,3,7,4,7,5,7,6,7,7. Depending on the type of medicines, a number of Sub-services have been defined. Full application On quality, safety and clinical development, or quality and clinical development, or safety and clinical development, or pre-referral advice of a file. Classification of unclassified variations and grouping of variations, according to Regulation (EC) 1234/2008 of the European Commission. About medicines for pediatric use Generic Medication, Medicinal Gas, MPT Plants and Well-established Use On clinical development, or quality and safety, or quality and bioequivalence studies. On quality, or safety, or bioequivalence studies Follow-up on clinical development, or quality and safety, or quality and bioequivalence studies. Follow-up on quality, or safety, or bioequivalence studies Classification of unclassified variations and for grouping variations, according to Regulation (EC) 1234/2008 of the European Commission About medicines for pediatric use
15 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE
16 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE Clinical trial. This service has been defined for the payment of fees for clinical trials. Fee Schedule and 5.3. Two Sub-services have also been defined. Evaluation of the first clinical trial with unauthorized drugs in a country belonging to the International Conference on Harmonization (ICH) with active ingredients that are not part of authorized medicinal products in Spain. Authorization under subparagraphs (a), (b), (c) and (d) With medicines authorized and registered in Spain or with medicines in research elaborated by a Service of Pharmacy
17 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE Ownership Transfer This service has been defined for the payment of ownership transfer of the medicines authorized by the AEMPS. The fees that are paid when selecting this service are: 4.6 Ownership transfer Homeopathic Medication 1.4 Fee for the ownership transfer of the authorization of a medicinal product for human use, or by modification of the holder's representative. 2.3 Fee for the procedure of ownership transfer of the authorization of an allergen medicine for diagnostic use. 3.4Transfer of authorization for a traditional herbal medicinal product (MTP) or a herbal medicinal product authorized by established use
18 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE Renewal of Authorization. This service has been defined for the payment of Five Year Renewals of the medicines authorized by the AEMPS. The fees that are paid when selecting this service are: 4.10 Procedure for renewal of the authorization of a homeopathic medicinal product WITHOUT an approved therapeutic indication 4.11 Procedure for renewal of authorization of a homeopathic medicinal product WITH approved therapeutic indication 1.8 Fee for the renewal of authorization procedure for a medicinal product for human use 2.3 Fee for the procedure for renewal of authorization of an allergen medicine for diagnostic use 3.8 Fee for the renewal of authorization procedure for a traditional herbal medicinal product (MTP) 3.9 Fee for the renewal of the authorization procedure for a herbal medicinal product authorized by well-established use
19 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE National Annual Fee This service has been defined for the payment of the Annual Medication Marketing Authorization. The fees that will be paid in this service are: 4.12 Simple annual fee for a homeopathic medicinal product for human use WITHOUT an approved therapeutic indication already authorized. 1.9 Simple annual maintenance fee for a medicinal product for human use already authorized 2.7 Type for simple annual declaration of intention to market an allergen medicine for diagnostic use 3.10 Simple annual fee for a traditional herbal medicinal product (MTP) already authorized 3.11 Simple annual fee for a traditional herbal medicinal product authorized by wellestablished use This option is only available from the Medication Marketing Notifications system. gin.aspx?opc=humana
20 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE Parallel Import. This service has been defined for the Parallel Import of medicines. In the case of the Parallel Import service, a series of Sub-services have been defined for the scope of medicinal products for human use, such as: Authorization Renewal Modification Notification The fees headings that are paid on this service and Subservices are 1.10 Fee for the authorization procedure for the 'parallel import' of a medicinal product for human use 1.11 Fee for the procedure for amending the authorization for the 'parallel importation' of a medicinal product for human use 1.12 Fee for the renewal of the authorization for the 'parallel importation' of a medicinal product for human use 1.13 Fee for import notification.
21 SERVICES OF DEPARTMENT OF MEDICINES FOR HUMAN USE Batch Release: certificates issued by the AEMPS for immunological medicines have been defined. For this service two Sub-services have been defined: Issuance of a European Certificate when batch analysis is required. Individual Application Between 6 and 10 year applications Between 11 and 40 applications year Between 41 and 160 applications year More than 160 applications year. European certificate issuance when bulk analysis is required The fees headings that are paid on this service and Subservices are: 1.14 Charge for the issuance of a European batch release certificate for vaccines and blood products for human use where the analysis of a medicinal product by lot is required 1.15a Rate for the release of batches of blood products and vaccines in accordance with Articles 41.4 and 43.3 of Royal Decree 1345/2007, of October b Rate for the release of batches of blood products and vaccines in accordance with articles 41.4 and 43.3 of Royal Decree 1345/2007, of October c Rate for the release of batches of blood products and vaccines in accordance with articles 41.4 and 43.3 of Royal Decree 1345/2007, of October d Rate for the release of batches of blood products and vaccines in accordance with articles 41.4 and 43.3 of Royal Decree 1345/2007, of October e Rate for the release of batches of blood products and vaccines in accordance with articles 41.4 and 43.3 of Royal Decree 1345/2007, of October Charge for the European certificate of batch release for vaccines and blood products for human use when the analysis of a bulk (bulk)
22 NEW ELECTRONIC PAYMENT SYSTEM DEPARTMENT OF INSPECTION AND CONTROL
23 SERVICES OF DEPARTMENT OF INSPECTION AND CONTROL On the Service tab you will choose: The Scope, which will match with each of the Departments of the AEMPS that provide services with payment of fees. The Type of Service The Type of Subservice where appropriate Type of medicines in your case
24 SERVICES OF DEPARTMENT OF INSPECTION AND CONTROL For the Department of Inspection and Control, services that are subject of payment have been defined. The services that can be paid through the electronic payment system for the aforementioned department are: Scientific advice Authorizations Certification Inspection Modification of authorization Registry
25 SERVICES OF DEPARTMENT OF INSPECTION AND CONTROL Scientific Advice. This service has been defined for the payment of fees under 7.10 scientific / technical on system design and manufacturing processes in accordance with good manufacturing rules. Certification. This service has been defined for the payment of the fees heading 7.1 Fee for issuing a certification. The types of certificates issued by the Department being obliged to pay the fee 7.1 are, among others: Certificate of free sale, sanitary certificate. Certificate of recognition of the Technical Director. Certifying Alcohol Tax. GMP certificate.
26 SERVICES OF DEPARTMENT OF INSPECTION AND CONTROL Authorizations. This service has been defined for the payment of fees related to all types of authorizations granted by the Department. SubServices have been defined for this service: Opening of a pharmaceutical laboratory. Procedure for authorizing the manufacture of drugs approved in other countries and not registered in Spain. Exceptional manufacture by third parties of medicinal products for human and / or veterinary use Drug stores under customs control or surveillance Of crops of plants that can be used for the manufacture of medicines, narcotics Export to intra-community countries and third countries of narcotic drugs and psychotropic and psychotropic drugs. The fee headings that are paid on this service are: 6.1Authorization opening pharmaceutical laboratory 6.5Procedure to authorize the manufacture of medicines approved in other countries and not registered in Spain 6.6Procedure of special authorization by third parties of medicinal products for human and veterinary use 6.7Procedure of authorization and / or certification of drug distribution warehouses: customs warehouses as well as free zones or free warehouses that store medicines 6.8Procedure of authorization of crops of plants that can be used for the manufacture of drugs, narcotic drugs and psychotropic substances Export authorizations for narcotic and psychotropic drugs to intra-community and third countries.
27 SERVICES OF DEPARTMENT OF INSPECTION AND CONTROL Modifications of Authorization. This service has been defined for the payment of fees related to the Modification of Authorization of Pharmaceutical Laboratories granted by the Department. SubServices have been defined for this service: Of a pharmaceutical laboratory for minor changes Of a pharmaceutical laboratory for major changes without an inspection visit Of a pharmaceutical laboratory for major changes with inspection visit The fees headings that are paid on this service are: 6.2 Pharmaceutical laboratory authorization modification for minor changes in the same 6.3 a) Procedure to modify the authorization of a pharmaceutical laboratory for major changes in the same, when the actions do not include an inspection visit. 6.3 b) Procedure to modify the authorization of a pharmaceutical laboratory for major changes in the same when the inspection actions include inspection visit
28 SERVICES OF DEPARTMENT OF INSPECTION AND CONTROL Inspection. This service has been defined for the payment of fees related to inspections of pharmaceutical laboratories carried out by the Department. SubServices have been defined for this service: Actions at the national level, unless denounced or requested by association / consumers Actions in third countries unless denounced or petitioned by association / consumers. Actions in third countries at the request of the interested party. The fees headings that are paid on this service are: 6.4A Individual inspections, except in cases of denunciation or at the request of a representative association of users or consumers, at the national level 6.4b Individual inspections, except in cases of denunciation or at the request of a representative association of users or consumers, in third countries 6.4c Individual inspections in non-compulsory third countries, at the request of the interested party
29 SERVICES OF DEPARTMENT OF INSPECTION AND CONTROL Registry. This service has been defined for the payment of fees related to the records kept by the Department. SubServices have been defined for this service: Registration, modification or updating of the registry of importing companies or distributors of active ingredients. Registration of entities for the intermediation of medicinal products for human use. The fee headings that are paid on this service are: 6.9 Initial registration, notification of mandatory changes or annual update of the registration of manufacturers, importers or distributors of active substances 6.10 Registration in the register of persons engaged in intermediation in the distribution of medicinal products for human use
30 NEW ELECTRONIC PAYMENT SYSTEM DEPARTMENT OF VETERINARY MEDICINES
31 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES On the Service tab you will choose: The Scope, which will match with each of the Departments of the AEMPS that provide services with payment of fees. The Type of Service The Type of Subservice where appropriate Type of medicines in your case
32 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES For the Department of Veterinary Medicines, there have been defined services that are subject of payment. The services that can be paid through the electronic payment system for the aforementioned department are: Batch Release Booking vacancy Certification Clinical trial Modification of authorization New register Ownership transfer Parallel import Renewal of authorization Maintenance in the market Scientific Advice Periodic safety reports.
33 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Batch Release: The certificates issued by the AEMS for immunological medicines have been defined as such. For this service, two Subservices have been defined, which match with the fees 9.13 and Issue of an European certificate of immunological medicinal product according to Article 81 of Directive 2001/82 / EC Issue of an European certificate of immunological veterinary medicinal products according to Article 82 of Directive 2001/82 / EC
34 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Booking Vacancy.It is only paid in case of decentralized procedures where Spain acts as an EMR. In this screen the type of medicines for which you want to make the booking vacancy will be chosen. The fee paid for this service is the 9.15 Fee for booking a vacancy to act as a Member State of Reference in a Decentralized or Mutual Recognition procedure." New register. We have thus defined the requests for authorization of new medicines, in the case of Human Use; Full application, Generics, Homeopathic with IT without IT. The fees paid for this services are : 9.1Fee for application for a marketing authorization for a veterinary medicinal product, except for the applications referred to in Article Fee for application for a marketing authorization for a generic veterinary medicinal product (dossier submitted under Article 17.3). 4.1 Assessment, authorization and registration of a new homeopathic medicinal product without approved therapeutic indication Fee for a national simplified procedure. A single strain 4.2 Assessment, authorization and registration of a new homeopathic medicinal product without approved therapeutic indication Fee for a national simplified procedure. BETWEEN TWO AND FIVE BAYS 4.3 Assessment, authorization and registration of a new homeopathic medicinal product without approved therapeutic indication Fee for a national simplified procedure. MORE THAN SIX BODIES 4.5 Evaluation, authorization and registration of a new Homeopathic Medication with approved therapeutic indication
35 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES
36 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Certification. We have defined this service for paying fees export certificates medicines Veterinarians, and all certifications that are paid with 7.1 Fee for issuing a certificate. Scientific Advice. We have thus defined the services provided by the AEMPS of scientific advice to the laboratories. These services are in line with the rate headings 7.2,7,3,7,4,7,5,7,6,7,7 Depending on the type of medicines, a number of Sub-services have been defined; Full application; On quality, safety and clinical development, or quality and clinical development, or safety and clinical development, or pre-referral advice of a file. Classification of unclassified variations and grouping of variations, according to Regulation (EC) 1234/2008 of the European Commission.
37 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Generic Medication, On clinical development, or quality and safety, or quality and bioequivalence studies. On quality, or safety, or bioequivalence studies Follow-up on clinical development, or quality and safety, or quality and bioequivalence studies. Follow-up on quality, or safety, or bioequivalence studies Classification of unclassified variations and for grouping variations, according to Regulation (EC) 1234/2008 of the European Commission
38 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Clinical trial. We have defined this service for the payment of fees for clinical trials y epigraphs rate. 5.4 Procedure for qualification as a product in the clinical research phase of an unauthorized veterinary medicinal product in Spain 5.5 Rate by procedure veterinary clinical trial. Two Sub-services have also been defined. Qualification of an unauthorized veterinary medicinal product in Spain. Veterinary clinical trial.
39 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Modification of Authorization. We have defined this service for payments of variations, groupings, work-sharing, super groups and parallel presentations. When we choose this service, we will pay the following fee headings with their exceptions, and specific considerations included in the law VARIACION MEDICAMENTO HUMAN AND VETERINARY USE. 4.4 Fee by the procedure of modification of the authorization of a Homeopathic Medicine without approved therapeutic indication 4.7Fee for the procedure of modification of the authorization of a Homeopathic Medicine with approved therapeutic indication, classified as of "major importance" Type II 4.8 Fee for the procedure of modification of the authorization of a Homeopathic Medication with approved therapeutic indication, classified as Type IB 4.9 Fee for the procedure of modification of authorization of a Homeopathic Drug with approved therapeutic indication, classified as Type IA 9.4 Fee for the procedure of modification of the authorization of a veterinary medicine, classified as "major importance" Type II 9.5 Fee for the procedure for modifying the authorization of a veterinary medicinal product, defined as Type IB 9.6 Fee for the procedure for modifying the authorization of a veterinary medicinal product, type IA (including IA types of immediate notification).
40 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES
41 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Ownership Transfer. This service has been defined for the payment of ownership transfer of the medicines authorized by the AEMPS. The fees that are paid when selecting this service are: 4.6Transmission of Ownership Homeopathic Medication 9.3 Fee for the transfer of ownership of the authorization of a veterinary medicinal product, or for modification of the owner's representative
42 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Parallel Import. This service has been defined for the Parallel Import Authorization. The fee to be paid if we choose this service is 9.9 Fee for the authorization procedure for the 'parallel import' of a veterinary medicinal product
43 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Renewal of Authorization. This service has been defined for the payment of Five Year Renewals of the medicines authorized by the AEMPS. The fees that are paid when selecting this service are: 4.10Procedure for renewal of the authorization of a homeopathic medicinal product WITHOUT an approved therapeutic indication 4.11 Procedure for renewal of authorization of a homeopathic medicinal product WITH approved therapeutic indication 9.7 Fee for the renewal of authorization procedure for a veterinary medicinal product
44 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES National Annual Fee. We have defined This service for the payment of the Annual Fee of Marketing Authorization. The headings of fees to be paid for this service are: 4.12 Simple annual fee for a homeopathic medicinal product for human use WITHOUT an approved therapeutic indication already authorized. 9.8 Fee for simple annual declaration of intention to market an already authorized veterinary medicinal product This option is available only from the application of Intention of commercialization of veterinary medicines. c=veterinaria
45 SERVICES OF DEPARTMENT OF VETERINARY MEDICINES Periodic safety reports. This service has been defined for the payment of Periodic Safety Reports. The headings of fees paid for this service are 9.10 Fee for evaluation of a bi-annual periodic safety report of a veterinary drug, whether or not the drug is registered in Spain Fee for evaluation of annual safety report of a veterinary drug, whether or not the drug is registered in Spain Fee for evaluation triennial or superior to three years whether or not the drug is registered in Spain. For this service a series of Sub-services have been defined: Biannual evaluation whether or not the medicine is registered in Spain Annual evaluation Whether or not the medicine is registered in Spain Triannual evaluation or mores than three years whether or not the medicine is registered in Spain
46 NEW TELEMATIC PAYMENT DEPARTMENT OF COSMETICS AND MEDICAL DEVICES
47 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES On the Service tab you will choose: The Scope, which will match with each of the Departments of the AEMPS that provide services with payment of fees. The Type of Service The Type of Subservice where appropriate Type of medicines in your case
48 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES For the Department of Medical Devices and Cosmetics, there have been defined some services that are subject of payment. The services that can be paid through the electronic payment system for the aforementioned department are: Certification Clinical trials of medical devices Inspection Modification and revalidation of products Modification of license Previous License Products Registry Registration and individual authorization of personal care products, disinfectants and repellents Renewal of license Responsible declaration of activities These services have been organized in two distinct areas: Medical devices Cosmetics and Personal Care Products.
49 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Medical Devices services: Certification Clinical trial of medical devices Modification and revalidation of products Modification of license Previous license Products Registry Renewal of license
50 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Certification. This service has been defined for the fees section payment 8.5 Procedure for certification issuing. Clinical trial of medical devices. This service has been defined for the fees section payment 8.9 Authorization for clinical research of medical devices.
51 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Previous license. This service has been defined for the payment of services granted by the department relating to operating license. For this type of service has been defined two Sub-services: Manufacturing and assembly and/or sterilization establishment Import establishment The fee headings that are paid on this service are: 8.12Procedure for pre-licensing of medical devices and disinfectants: manufacturing establishment, grouping 8.13Procedure of prior license for the operation of medical devices and disinfectants: import establishment
52 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Modification of license. This service has been defined for the payment of services granted by the department relating to operating license modification. For this type of service has been defined three Sub-services: License prior to the operation of manufacturing and grouping establishment and/or sterilization License prior to the operation of import establishments License prior to the operation of establishments that do not affect the site The fee headings that are paid on this service are: 8.14 Procedure for modification of the previous license to operate medical devices and disinfectant establishments in relation to their location: manufacturing establishment, grouping 8.15 Procedure for modification of the previous license of operation of medical devices and disinfectant establishments in relation to their location: import establishment 8.16 Procedure for modification of the previous license of operation of medical devices and disinfectant establishments
53 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Modification and revalidation of products. This service has been defined for the payment of services granted by the department relating to modification and revalidation of products. The fee headings that are paid on this service are 8.33 Procedure for the modification of medical devices Product Registry. This service has been defined for the payment of services granted by the department relating to Medical Device. The fee headings that are paid on this service are 8.3 Procedure for registration and registration of Medical Devices.
54 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Licence Renewal. This service has been defined for the payment of services granted by the department relating to Licence Renewal. For this type of service has been defined two Sub-services Renewal of manufacturing establishments, grouping and sterilization. Renewal of import establishments. The fee headings that are paid on this service are: 8.17 Procedure for the revalidation of the license of establishments of medical devices and disinfectants: manufacturing establishment 8.18 Procedure for the revalidation of the license of establishments for medical devices and disinfectants: import establishment
55 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES The services defined for Cosmetics and Personal Care Products, Repellents and Disinfectants are: Certification Inspection Modification and revalidation of products Modification of license Previous License Registration and individual authorization of personal care products, disinfectants and repelents Renewal of license Responsible declaration of activities
56 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Certification. This service has been defined for the fees section payment 8.5 Procedure for certification issuing Inspection. This service has been defined for the fees section payment Individual inspections for the verification of the responsible declaration
57 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Responsable declaration of activities, this service has been defined for the payment of the services granted by the departments relating to the presentation of the responsible declaration of activities. For this type of service has been defined Subservicios: Checking and control manufacturing Checking and control import Checking and control manufacturing modification Checking and control import modification. The fee headings that are paid on this service are: 8.6 Procedure for verification and control of the declaration responsible for the manufacturing activity of cosmetics and personal care products 8.7 Procedure for verification and control of the declaration responsible for the import of cosmetic products and personal care 8.8 Procedure for verification and control of the declaration responsible for changes in the manufacturing activity of cosmetics and personal care products 8.9 Procedure for verification and control of the declaration responsible for changes in the import activity of cosmetics and personal care products
58 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Previous license. This service has been defined for the payment of services granted by the department relating to operating license. For this type of service has been defined two Sub-services: Import establishment Manufacturing establishment The fee headings that are paid on this service are: 8.12Procedure for pre-licensing of medical devices and disinfectants: manufacturing establishment, grouping 8.13Procedure of prior license for the operation of medical devices and disinfectants: import establishment
59 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Lincese Modification. This service has been defined for the payment of services granted by the department relating to operating license modification. For this type of service has been defined three Sub-services: License prior to the operation of manufacturing establishment License prior to the operation of import establishment License prior to the operation of establishment(minor modification). The fee headings that are paid on this service are: 8.14 Procedure for modification of the previous license to operate medical devices and disinfectant establishments in relation to their location: manufacturing establishment, grouping 8.15 Procedure for modification of the previous license of operation of medical devices and disinfectant establishments in relation to their location: import establishment 8.16 Procedure for modification of the previous license of operation of medical devices and disinfectant establishments
60 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Modification and revalidation of products. This service has been defined for the payment of services granted by the department relating to personal care products and disinfectants. The fee headings that are paid on this service are 8.4 Procedure for modification and validation of hygiene products and disinfectants
61 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Individual registration and authorization of products for personal care and disinfectants. This service has been defined for payment of services provided by the Department for Registration and authorization individualized personal care products and disinfectants. The fee heading paid for this service 8.2 Procedure for registration and individual authorization of personal care products and disinfectants
62 SERVICES OF DEPARTMENT OF COSMETICS AND MEDICAL DEVICES Licences Renewal: This service has been defined for the payment of services granted by the department relating to Licence Renewal. For this type of service has been defined two Sub-services Manufacturing plant Renewal. Import plants Renewal. The fee headings that are paid on this service are: 8.17 Procedure for the revalidation of the license of establishments of sanitary products and disinfectants: manufacturing establishment 8.18 Procedure for the revalidation of the license of establishments for sanitary products and disinfectants: import establishment
63 NEW ELECTRONIC PAYMENT SYSTEM NOTIFIED BODY
64 SERVICES OF NOTIFIED BODY On the Service tab you will choose: The Scope, which will match with each of the Departments of the AEMPS that provide services with payment of fees. The Type of Service The Type of Subservice where appropriate Type of medicines in your case For Notified Body, there have been defined services that are subject of payment. The services that can be paid through the electronic payment system are: Audit Certification
65 SERVICES OF NOTIFIED BODY Audit. This service has been defined for the payment of fees related to all types of Audits performed by Notified Body. SubServices have been defined for this service: According to the complete Quality Assurance System According to quality assurance of production According to product quality assurance Monitoring and extension of certification Supplementary and repetition site The rate headings that are paid on this service are: 8.26 Initial audit under a complete quality assurance system 8.27 Initial audit in accordance with production quality assurance 8.28 Initial audit under product quality assurance 8.29 Follow-up and extension of CE marking certification 8.30 Supplementary and repeat room audits
66 Certification. This service has been defined for the payment of fees related to all types of Certifications granted by Notified Body. SubServices have been defined for this service: Evaluation of active substance Evaluation of CE marking by complete system Evaluation of the CE marking by examination of type and quality of production or by verification or quality of the product Evaluation of CE marking by conformity of type and quality of production or by verification or quality of the product Verification of products and batches Evaluation of CE marking by design examin Modification of administrative data of the CE marking Extension of the CE marking Certification The rate headings that are paid on this service are: 8.20 Evaluation report of the active substance incorporated into a medical device SERVICES OF NOTIFIED BODY 8.5Procedure for issuing a certification 8.21Evaluation of certification files for CE marking of health products belonging to the same family by complete quality assurance system 8.22Evaluation of CE marking certification dossiers 8.23Evaluation of CE marking certification dossiers 8.24Verification of products and batches of products 8.25Evaluation of certification dossiers for CE marking of medical devices by CE design examination 8.31Modification of administrative data in the certification of CE marking 8.32Procurement of CE marking certifications
67 FEES AND SUMMARY Pressing Next button, we will go to the Fee screen. In this screen we will find the display with all the services selected in the previous screen, specifications and considerations exceptional circumstances of each services defined for the article 123 of the law. Pressing Next button, we will go to Summary screen, where we will find the information about fees, payer and selected services. We can find at the end of the screen, information about the diferents ways of payment.
68 WAYS OF PAYMENT Electronic Payment: Pressing the button will appear the following warning You will access the Caixa's electronic payment screen. The data that have been entered in the previous screen will appear in this one: Number of the proof of payment, VAT number o registration company number and amount to pay. You can pay with credit card or with open line la Caixa. Once payment is completed, the user must press return button to obtain the proof of payment.
69 WAYS OF PAYMENT Download Model When the button is pressed, a screen will appear with the available payment methods We will choose one of them. Pressing the Continue button will take us to the last screen where we can obtain the proof of payment.
STATUTORY INSTRUMENTS. S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS 2018
STATUTORY INSTRUMENTS. S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS 2018 2 [531] S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS
More informationSchedule 1. New marketing authorisation and renewal of marketing authorisation
and renewal of marketing Schedule 1 The Delimitation column refers to the relevant articles of Directive 2001/83/EC of the European Parliament and the Council of 6 November 2001 on the Community code relating
More informationSTATUTORY INSTRUMENTS. S.I. No. 599 of 2015 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) REGULATIONS 2015
STATUTORY INSTRUMENTS. S.I. No. 599 of 2015 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) REGULATIONS 2015 2 [599] S.I. No. 599 of 2015 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) REGULATIONS 2015 I, KATHLEEN
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationThis is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices
agencia española de medicamentos y productos sanitarios This is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices ROYAL DECREE
More informationUnofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control
Unofficial translation /Ministry of Social Affairs and Health No. 548/2008 Government Decree on Narcotics Control Issued in Helsinki on 28 August 2008 Section 1 Scope of application This Decree lays down
More informationMEDICINES ACT 395/1987. Unofficial translation; Amendments up to 1340/2010 included
MEDICINES ACT 395/1987 Unofficial translation; Amendments up to 1340/2010 included Chapter 1 General provisions Objectives Section 1 (80/2003) The objective of this Act is to maintain and promote the safety
More informationMedicines and Cosmetics Regulation Unvalidated References:
Medicines and Cosmetics Regulation 2002 Unvalidated References: This reprint of this Statutory Instrument incorporates all amendments, if any, made before 25 November 2006 and in force at 16 May 2002....
More informationUNITED ARAB EMIRATES
GUIDELINES OF IMPORTS FOR THE TRADE EMIRATES AUTHORITY FOR STANDARDIZATION & METROLOGY UNITED ARAB EMIRATES EMIRATES CONFORMITY ASSESSMENT SCHEME (ECAS) HALAL CERTIFICATION Date issued : 14/03/2017 Last
More informationGUIDELINES OF IMPORTS FOR THE TRADE EMIRATES CONFORMITY ASSESSMENT SCHEME (ECAS) HALAL CERTIFICATION - MIDDLE EAST
EMIRATES CONFORMITY ASSESSMENT SCHEME (ECAS) HALAL CERTIFICATION - MIDDLE EAST DATE ISSUED : 11/05/2017 LAST MODIFICATION : 11/05/2017 GUIDELINES OF 1. ESMA HALAL AUDITS MANDATE PROGRAM NAME PROGRAM MANDATED
More informationThis Administrative regulation will come into force on 1 st August 2013 and will remain so until further notice.
Administrative regulation 01.08.2013 Dnro 4000/03.01.01/2012 2/2013 UNOFFICIAL TRANSLATION Finnish Medicines Agency Administrative Regulation APPLYING FOR AND MAINTAINING A MARKETING AUTHORI- SATION AND
More informationMEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH
11 MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH Background The rules in this section are designed to ensure that advertisements that include health claims (please see Section 13 for health claims
More informationDIRECTIVES. (Text with EEA relevance)
L 238/44 DIRECTIVES COMMISSION DIRECTIVE (EU) 2017/1572 of 15 September 2017 supplementing Directive 2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of
More informationAct on Narcotic Drugs and Psychotropic Substances and Precursors thereof
Issuer: Riigikogu Type: act In force from: 13.05.2016 In force until: 22.11.2018 Translation published: 06.05.2016 Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof Amended by the
More informationThe fighting in Spain against counterfiting: the Directive and the Delegated Act
The fighting in Spain against counterfiting: the Directive and the Delegated Act Belén Escribano Head of the Pharmaceutical Inspection and Enforcement Department 1 Overview Background Directive implementation
More informationPROVISIONAL TRANSLATION
- 3 - CROATIAN PARLIAMENT 1035 Pursuant to Article 88 of the Constitution of the Republic of Croatia, I hereby issue the DECISION PROMULGATING THE ACT ON AMENDMENTS TO THE MEDICINAL PRODUCTS ACT I hereby
More informationThis Administrative regulation will come into force on 1 st January 2018 and will remain so until further notice. Administrative Regulation No 3/2015
Administrative regulation 15.12.2017 Dnro 007313/00.01.02/2017 02/2017 UNOFFICIAL TRANSLATION Finnish Medicines Agency Administrative Regulation APPLYING FOR AND MAINTAINING A MARKETING AUTHORI- SATION
More informationRegulatory Framework for Medical Devices in South Africa. 23 November 2018 Andrea Keyter Deputy Director: Medical Devices
Regulatory Framework for Medical Devices in South Africa 23 November 2018 Andrea Keyter Deputy Director: Medical Devices Medicines and Related Substances Act, 1965 (Act 101 of 1965) Act 72 of 2008 and
More informationTable of ConTenTs. 1. The Agencia Española de Medicamentos y Productos Sanitarios, AEMPS: Who we are. 2. How are medicines assessed and authorised?
Table of ConTenTs 1. The Agencia Española de Medicamentos y Productos Sanitarios, AEMPS: Who we are Mission and vision Summary of activity The human team Structure 2 3 4 6 7 2. How are medicines assessed
More informationREPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD
REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD Ensuring the provision of quality, safe and efficacious pharmaceutical products and services. FUNCTIONS OF THE BOARD BACKGROUND
More informationREPUBLIC OF LITHUANIA LAW ON PHARMACY 22 June 2006 No X-709 Vilnius CHAPTER I GENERAL PROVISIONS
REPUBLIC OF LITHUANIA LAW ON PHARMACY 22 June 2006 No X-709 Vilnius CHAPTER I GENERAL PROVISIONS Article 1. Purpose of the Law 1. This Law shall regulate pharmaceutical and other activity related to medicinal
More informationDraft Regulations on granting of licences for parallel import of medicinal products
REGULATION on granting of licences for parallel import of medicinal products for human use and veterinary use. Art. 1. Scope and definitions. This regulation applies to granting of parallel import licences
More informationWashoe County Medical Marijuana Establishment Business License Common Questions
Washoe County Medical Marijuana Establishment Business License Common Questions 1. What is a medical marijuana establishment? The Nevada State Constitution authorizes patients, on the advice and with written
More informationRequirements to the Registration of Medicinal products in the Republic of Armenia
Requirements to the Registration of Medicinal products in the Republic of Armenia Yerevan 2010 Requirements to the Registration of Medicinal products in the Republic of Armenia Current requirements to
More informationORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies
ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies ISSUING BODY: The Ministry of Health published in: the Official
More informationDIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004
30.4.2004 Official Journal of the European Union L 136/85 DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 amending, as regards traditional herbal medicinal products,
More informationCODE OF STATUTES MEDICAL PRODUCTS AGENCY
CODE OF STATUTES MEDICAL PRODUCTS AGENCY Publisher: Christina Åkerman, Director-General. LVFS 2012:19 Published 4 July 2012. The Medical Products Agency s Provisions on Parallel Imported Medicinal Products;
More informationIndustry s Perspective on the Status of Medical Device Regulations. FUNDISA Workshop 09 & 10 Oct Anele Vutha SAMED Regulatory Committee
Industry s Perspective on the Status of Medical Device Regulations FUNDISA Workshop 09 & 10 Oct 2014 Anele Vutha SAMED Regulatory Committee Today s Topics: 1. Medical Device Definition - Differences 2.
More informationOREGON MEDICAL MARIJUANA ACT
OREGON MEDICAL MARIJUANA ACT 475.300 Findings. The people of the state of Oregon hereby find that: (1) Patients and doctors have found marijuana to be an effective treatment for suffering caused by debilitating
More informationBMA INFORMATION BULLETIN No. 23. International Safety Management (ISM) Code
BMA INFORMATION BULLETIN No. 23 International Safety Management (ISM) Code Guidance and instructions for Ship-owners, Managers, Masters, Bahamas Recognised Organisations and Bahamas Approved Inspectors
More informationKEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE
RNI Conseil 2017 Tous droits réservés Toute reproduction interdite sans l'autorisation de l'auteur. KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE Anne Laure TARDY, PhD
More informationREGULATORY REQUIREMENTS FOR REGISTRATION OF HEALTH SUPPLEMENTS IN MALAYSIA
REGULATORY REQUIREMENTS FOR REGISTRATION OF HEALTH SUPPLEMENTS IN MALAYSIA TAN JAS MIN National Pharmaceutical Regulatory Agency Ministry of Health Malaysia Email address: tanjasmin@npra.gov.my ORGANISATION
More informationGCC Guide for Control on Imported Foods
Secretariat General of the Gulf Cooperation Council The Cooperation Council for the Arab States of the Gulf GCC GCC Guide for Control on Imported Foods Dr. BANDAR M. ALODIANI April 2018 1 Introduction:
More informationMEDICINES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF FOOD/NUTRITIONAL/DIETARY SUPPLEMENTS IN THE GAMBIA
MEDICINES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF FOOD/NUTRITIONAL/DIETARY SUPPLEMENTS IN THE GAMBIA Document No.: MCA/NSG/17/11/01 Date of Adoption: 20 th January 2017 Date of Issue: 25 th July 2017
More informationquality and safety of pharmacy preparations in Europe
quality and safety of pharmacy preparations in Europe Henk Scheepers, Pharm D, Senior-Inspector Public Health Supervisory Service Health Care Inspectorate The Netherlands 1 Nothing to disclose 2 1 quality
More informationHealth Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:
Health Authority Abu Dhabi Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: PPR/DMP/DR/P0001 Version 0.9 Approval Date: August 2007 Effective Date: August 2007 Last
More informationMedical Devices. SOUTH AFRICA Bowman Gilfillan
Medical Devices SOUTH AFRICA Bowman Gilfillan CONTACT INFORMATION Llewellyn Parker Bowman Gilfillan PO Box 785812, Sandton, 2146 South Africa +27 11 669 9635 l.parker@bowman.co.za www.bowman.co.za 1. Definition
More informationSECTION PRESCRIPTIONS
SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or
More informationRecall Guidelines. for Chinese Medicine Products
Recall Guidelines for Chinese Medicine Products April 2018 Recall Guidelines for Chinese Medicine Products Chinese Medicines Board Chinese Medicine Council of Hong Kong Compiled in September 2005 1 st
More informationPHYSIOTHERAPY ACT AUTHORIZATION REGULATIONS
c t PHYSIOTHERAPY ACT AUTHORIZATION REGULATIONS PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this regulation, current to July 11, 2009. It is intended
More informationDECREE. President of Islamic Republic of Afghanistan Regarding the enforcement of Medicine Law
Number: (116) Date: 18 th November 2008 Article 1: DECREE Of President of Islamic Republic of Afghanistan Regarding the enforcement of Medicine Law I, hereby, enforce the Law on Medicine which is approved
More informationCosts and Limitations
Costs and Limitations For Certified Healthcare IT EHR EMR Version 10.0 07/14/2017 Penn Medical Informatics Systems, Inc Costs and Limitations for EyeDoc EMR Version 10.0 Capability and Description 2014
More informationOn Medicinal Products and Medical Devices
UNITED NATIONS United Nations Interim Administration Mission in Kosovo UNMIK Mission d Administration NATIONS UNIES Intérimaire des Nations Unies au Kosovo PROVISIONAL INSTITUTIONS OF SELF GOVERNMENT Law
More informationIC ARTICLE 20. HEARING AID DEALERS. IC Chapter 1. Regulation of Hearing Aid Dealers; Creation of Advisory Committee; Certificates
IC 25-20 ARTICLE 20. HEARING AID DEALERS IC 25-20-1 Chapter 1. Regulation of Hearing Aid Dealers; Creation of Advisory Committee; Certificates IC 25-20-1-1 Definitions Sec. 1. Except as the context requires
More informationGENERAL INFORMATION AND INSTRUCTIONS
NON-PARTICIPATING MANUFACTURER CERTIFICATION FOR LISTING ON OREGON DIRECTORY GENERAL INFORMATION AND INSTRUCTIONS Who is required to file this Certification? Any tobacco product manufacturer who is a non-participating
More informationSub. S.B. 119 As Passed by the Senate
AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,
More informationThe proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below.
ADVISORY Food & Drug FDA ISSUES PROPOSED RULE TO ESTABLISH A UNIQUE DEVICE IDENTIFICATION SYSTEM FOR MEDICAL DEVICES July 16, 2012 On July 11, 2012, the Food and Drug Administration (FDA) published in
More informationMEDICINAL PRODUCTS ACT. UNOFFICIAL CONSOLIDATED TEXT (ZZdr-1-NPB1) I. GENERAL PROVISIONS. Article 1 (scope of regulation and competence)
The Agency for Medicinal Products and Medical Devices of the Republic of Slovenia has prepared the unofficial consolidated text for the Medicinal Products Act which includes: Medicinal Products Act (Official
More informationtation DEVELOPMENTAL PROGRAMS BULLETIN COMMONWEALTH OF PENNSYLVANIA DEPARTMENT OF PUBLIC WELFARE EFFECTIVE DATE: April 8, 2014 BY:
tation DEVELOPMENTAL PROGRAMS BULLETIN COMMONWEALTH OF PENNSYLVANIA DEPARTMENT OF PUBLIC WELFARE DATE OF ISSUE: April 8, 2014 EFFECTIVE DATE: April 8, 2014 NUMBER 00-14-04 SUBJECT: Accessibility of Intellectual
More informationREGULATORY CHALLENGES IN SOUTH AFRICA
REGULATORY CHALLENGES IN SOUTH AFRICA MEDICINES CONTROL COUNCIL SA Prof Peter Eagles Chairperson Medicines Control Council [Southern African Regional and International Symposium (SARI 2014)] 1 OUTLINE
More informationCertification in the scope of Customs Union Russia Belarus Kazakhstan
«Trade conditions with the Russian Federation» Certification in the scope of Customs Union Russia Belarus Kazakhstan Uliana Karpekina senior lawyer, head of commercial practice group September 16, 2010
More informationCVA Program Handbook Missouri Veterinary Medical Association
CVA Program Handbook Missouri Veterinary Medical Association Revised June 1, 2015 Page 1 Revised June 1, 2015 Revised June 1, 2015 Page 2 MVMA CVA Program - Our Purpose The Certified Veterinary Assistant
More informationNOTICE TO APPLICANTS
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Food and feed safety, innovation Animal nutrition, veterinary medicines NOTICE TO APPLICANTS VETERINARY MEDICINAL PRODUCTS VOLUME 6A Procedures
More informationFoodDrinkEurope Position on GLP studies
FoodDrinkEurope Position on GLP studies Content of the presentation Introduction to GLP Importance of GLP for the food industry Use of GLP based on the example of novel foods Conclusions GLP what is it?
More informationMedical Devices Act 1
Issuer: Riigikogu Type: act In force from: 01.01.2016 In force until: 31.05.2016 Translation published: 01.02.2016 Medical Devices Act 1 Amended by the following acts Passed 13.10.2004 RT I 2004, 75, 520
More informationArticle 18. 5) Act No. 108/2000, Article 1. 6) Act No. 83/2004, Article 1. 7) Act No. 167/2007, Article 74.
Medicinal Products Act, No. 93/1994, as amended by Act No. 122/1994, No. 131/1994, No. 55/1995, No. 118/1995, No. 153/1996, No. 10/1997, No. 82/1998, No. 77/2000, No. 108/2000, No. 173/2000, No. 16/2001,
More informationREGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.
REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011. CHAPTER I Scope and definitions. Article 1 Scope.
More informationREGULATIONS OF THE PLYMOUTH BOARD OF HEALTH FOR TOBACCO SALES IN CERTAIN PLACES & SALE OF TOBACCO PRODUCTS TO MINORS
REGULATIONS OF THE PLYMOUTH BOARD OF HEALTH FOR TOBACCO SALES IN CERTAIN PLACES & SALE OF TOBACCO PRODUCTS TO MINORS A. Statement of Purpose: Whereas there exists conclusive evidence that tobacco smoke
More informationREGULATION (EC) No.141/2000
REGULATION (EC) No.141/2000 Community legislation in force Document 300R0141 Directory chapters where this document can be found: [15.30 Health promotion] Regulation (EC) No.141/2000 of the European Parliament
More informationLEAF Marque Assurance Programme
Invisible ISEAL Code It is important that the integrity of the LEAF Marque Standard is upheld therefore the LEAF Marque Standards System has an Assurance Programme to ensure this. This document outlines
More informationCOMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES
COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental
More informationResearch on the Administrative Rules of APIs, Pharmaceutical Excipients and Auxiliary Materials Master File. Translation version
Research on the Administrative Rules of APIs, Pharmaceutical Excipients and Auxiliary Materials Master File Division of Pharmaceuticals Department of Drug Registration Hou Renping Translation version Main
More informationLegislative Counsel s Digest:
Senate Bill No. 250 Senator Carlton (by request) CHAPTER... AN ACT relating to dentistry and dental hygiene; revising various provisions governing the qualifications, examination and licensure of dentists
More informationADOPTED TEMPORARY REGULATION OF THE NEVADA TAX COMMISSION
Chapter 453D of NAC ADOPTED TEMPORARY REGULATION OF THE NEVADA TAX COMMISSION LCB File No. T002-17 Filed with the Secretary of State on May 8, 2017 EXPLANATION - Matter in italics is new; matter in brackets
More informationVolume of Colorado Commission for the Deaf and Hard of Hearing (12 CCR )
Disclaimer: On-line versions of these regulations are the most current versions available; however, these are not official publication. For official publication of these and all State of Colorado regulations,
More informationProcedure. Identify all possible radiation hazards.
Guidance Notes on Radiation Risk Assessment Prior to commencing any new work practice involving a source of ionising radiation it is important that a realistic assessment of the radiation risks is carried
More informationEUROPEAN UNION. Brussels, 15 October 2007 (OR. en) 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621
EUROPEAN UNION THE EUROPEAN PARLIAMT Brussels, 15 October 2007 (OR. en) THE COUNCIL 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: Regulation
More informationGuideline on Health Food Exportation to China
Guideline on Health Food Exportation to China 2018 Version Editor: CIRS Food Technical Team Tel: +86 571 87206538 Email: food@cirs-group.com 0 Foreword Chinese consumer s consumption of health food was
More informationLAW ON PREVENTION AND SUPPRESSION OF THE ABUSE OF NARCOTIC DRUGS
LAW ON PREVENTION AND SUPPRESSION OF THE ABUSE OF NARCOTIC DRUGS CHAPTER I. GENERAL PROVISIONS Article 1 (Purpose of this Law) This Law is enacted in the implementation of the Single Convention on Narcotic
More informationTHE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL AN ACT
PRINTER'S NO. THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL No. Session of INTRODUCED BY LEACH AND FARNESE, FEBRUARY, REFERRED TO LAW AND JUSTICE, FEBRUARY, AN ACT 1 1 1 Providing for personal use of
More informationREGULATION TO ENSURE THE SANITARY AND SAFE OPERATION OF ADULT-USE MARIJUANA ESTABLISHMENTS AND THE SALE OF ADULT-USE MARIJUANA
REGULATION TO ENSURE THE SANITARY AND SAFE OPERATION OF ADULT-USE MARIJUANA ESTABLISHMENTS AND THE SALE OF ADULT-USE MARIJUANA A. Statement of Purpose and Authority: Whereas, Massachusetts voters approved
More informationFood Safety Regulation Chapter One Definitions
Food Safety Regulation Chapter One Definitions Article (1): In the application of the provisions of these regulations, words and terms herein shall have the meanings stated in Food Safety Law. The following
More informationMedical gap arrangements - practitioner application
Medical gap arrangements - practitioner application For services provided in a licensed private hospital or day hospital facility (Private Hospital) only. Please complete this form to apply for participation
More information4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch
Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,
More informationBILATERAL SCREENING MEETING
Negotiating Group for the Accession of the Republic of Serbia to the European Union - Chapter 28, Consumer and Health Protection BILATERAL SCREENING MEETING Chapter 28 Consumer and Health Protection Brussels,
More informationRULES. on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I
RULES on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I Article 1 Purpose The purpose of these Rules is to define and explain the product choices of the State Alcohol and Tobacco
More informationDrug Administration Law of the People's Republic of China Order of the President of the Peoples Republic of China. (No. 45)
Drug Administration Law of the People's Republic of China Order of the President of the Peoples Republic of China (No. 45) The Drug Administration Law of the People s Republic of China, revised at the
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
SOP details SOP title: SOP number: SOP category: Version number: 03 Version date: 19 December 2016 Effective date: 19 January 2017 Revision due date: 19 January 2020 NEWCASTLE CLINICAL TRIALS UNIT STANDARD
More informationSOCIALIST REPUBLIC OF VIET NAM Independence Freedom Happiness Ha Noi, day 14 month 06 year THE NATIONAL ASSEMBLY No: 34/2005/QH11
THE NATIONAL ASSEMBLY No: 34/2005/QH11 SOCIALIST REPUBLIC OF VIET NAM Independence Freedom Happiness Ha Noi, day 14 month 06 year 2005 LAW ON PHARMACY Pursuant to the 1992 Constitution of the Socialist
More informationMEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO
MEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO LEGAL FRAMEWORK General Health Act (1986): Established a National Health System in Spain in accordance with the following
More informationDocument Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the
Document Details Title Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No 1506-41174 Local Ref (optional) Main points the Active immunisation against infection caused by Hepatitis
More informationCHAPTER Section 3 of P.L.1983, c.296 (C.45: ) is amended to read as follows:
CHAPTER 121 AN ACT concerning the practice of physical therapy, amending P.L.2003, c.18, and amending and supplementing P.L.1983, c.296. BE IT ENACTED by the Senate and General Assembly of the State of
More informationFOOD AND DRUGS AUTHORITY (FDA) GHANA
REGULATION OF HERBAL MEDICINE IN GHANA FOOD AND DRUGS AUTHORITY (FDA) GHANA 1 PRESENTATION OUTLINE Background Mandate Functions General overview Regulation of Herbal Medicine Cooperation in the ECOWAS
More informationRisk analysis for veterinary vaccines in Australia
Risk analysis for veterinary vaccines in Australia Sam Hamilton Office of the Chief Veterinary Officer Australian Department of Agriculture, Fisheries and Forestry Overview Australia s animal health system
More informationGUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE
CAMEVET PROCEEDINGS II REVIEW DATE in BRAZIL: HOMEOPATHIC COMMISSION - SINDAN August 18, 2016 GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE SÃO PAULO, BRAZIL August 2016 Page 2 of 9 GUIDE TO
More informationReview of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy
Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy Introduction 1. The consolidation and review of the UK medicines legislation (including the Medicines
More informationWHEREAS, the Tennessee General Assembly finds that thousands of Tennesseans are
AN ACT to license sign language interpreters WHEREAS, the Tennessee General Assembly finds that thousands of Tennesseans are individuals who are Deaf, Deaf-Blind, or Hard of Hearing; and WHEREAS, the General
More informationImporting pre-packaged foods
Importing pre-packaged foods Information for those who wish to import pre-packa Starting your business This brochure provides important information for those who wish to import and sell pre-packaged foods
More informationGENERAL TERMS AND CONDITIONS WCO PUBLICATIONS
Version 1.0 GENERAL TERMS AND CONDITIONS WCO PUBLICATIONS These General Terms and Conditions govern all sales of Publications, on paper and/or in digital format whether directly at the Sales Counter or
More informationMEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA
MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA Document No.: MCA/HMPG/17/12/01 Date of Adoption: 20 th January 2017 Date of Issue: 25 th July 2017 Version
More informationECOCERT CANADA LABELLING GUIDE. For Canadian Certified Organic Products. Version3
ECOCERT CANADA LABELLING GUIDE For Canadian Certified Organic Products Version3 2014 TABLE OF CONTENTS Validation of label design........3 Use of the Ecocert Trademark....4 Changes to labels.... 4 Prerequisites
More informationAnnouncement regarding the publication of the results of clinical trials in accordance with Section 42b of the Medicines Act (AMG)
Federal Gazette No 127 dated 24 August 2011, p. 2975-2977 Federal Ministry of Health Announcement regarding the publication of the results of clinical trials in accordance with Section 42b of the Medicines
More information(Legislative acts) REGULATIONS
31.12.2010 Official Journal of the European Union L 348/1 I (Legislative acts) REGULATIONS REGULATION (EU) No 1235/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 15 December 2010 amending, as regards
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL ACCESS to and CONTROL of MEDICAL DEVICES and IVDs This guideline is intended to provide recommendations to Manufacturers, Importers, Exporters, Distributors, Wholesalers and Holders
More informationOCCUPATIONAL AND PROFESSIONAL LICENSING OPTOMETRIC PRACTITIONERS CONTINUING EDUCATION
TITLE 16 CHAPTER 16 PART 13 OCCUPATIONAL AND PROFESSIONAL LICENSING OPTOMETRIC PRACTITIONERS CONTINUING EDUCATION 16.16.13.1 ISSUING AGENCY: New Mexico Board of Optometry. [10-14-95; 2-15-99; 16.16.13.1
More informationQuality, Safety and Sourcing in Unlicensed Medicines
Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?
More informationIPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope
IPEC Europe Observations and Recommendations on Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human
More informationTHE CROATIAN PARLIAMENT DECISION
THE CROATIAN PARLIAMENT Pursuant to Article 89 of the Constitution of the Republic of Croatia, I hereby issue the DECISION PROMULGATING THE MEDICINAL PRODUCTS ACT I hereby promulgate the Medicinal Products
More information